European league against Rheumatism Sjögren's syndrome disease activity index and European League Against Rheumatism Sjögren's syndrome patient-reported index: A complete picture of primary Sjögren's syndrome patients

Arthritis Care and Research

Volumn 65, Issue 8, 2013, Pages 1358-1364

  Seror, R ^a,r   Gottenberg, J E ^b   Devauchelle Pensec, V ^c   Dubost, J J ^d   Le Guern, V ^e   Hayem, G ^f   Fauchais, A L ^g   Goeb, V ^h   Hachulla, E ⁱ   Hatron, P Y ⁱ   Larroche, C ^j   Morel, J ^k   Pedriger, A ^l   Puechal, X ^e   Rist, S ^m   Saraux, A ^c   Sene, D ⁿ   Sibilia, J ^b   Vittecoq, O ^o   Zarnitsky, C ^p   Labetoulle, M ^q   Ravaud, P ^r   Mariette, X ^a   more..

^a UNIVERSITÉ PARIS SACLAY   (France)

^b UNIVERSITY HOSPITAL OF STRASBOURG   (France)

^c UNIVERSITÉ DE BRETAGNE OCCIDENTALE   (France)

^d SERVICE DE RHUMATOLOGIE   (France)

^e AP HP ^*  (France)

^f UNIVERSITÉ PARIS DESCARTES   (France)

^g LIMOGES UNIVERSITY HOSPITAL   (France)

^h AMIENS UNIVERSITY HOSPITAL   (France)

ⁱ UNIV LILLE   (France)

^j AVICENNE HOSPITAL   (France)

^k UNIV MONTPELLIER   (France)

^l SERVICE DE RHUMATOLOGIE   (France)

^m CENTRE HOSPITALIER RÉGIONAL D ORLÉANS   (France)

ⁿ HÔPITAL LARIBOISIÈRE   (France)

^o UNIVERSITY OF ROUEN   (France)

^p LE HAVRE HOSPITAL   (France)

^q BICÊTRE HOSPITAL   (France)

^r HÔTEL DIEU   (France)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE ACTIVITY SCORE; DISEASE ASSOCIATION; DISEASE DURATION; EUROPEAN LEAGUE AGAINST RHEUMATISM SJOGREN SYNDROME DISEASE ACTIVITY INDEX; EUROPEAN LEAGUE AGAINST RHEUMATISM SJOGREN SYNDROME PATIENT REPORTED INDEX; FATIGUE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIMARY SJOEGREN SYNDROME; RATING SCALE; SJOEGREN SYNDROME; XEROSTOMIA;

AGED; DIAGNOSTIC SELF EVALUATION; FEMALE; FRANCE; HUMANS; MALE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); SJOGREN'S SYNDROME;

EID: 84881323706     PISSN: 2151464X     EISSN: 21514658     Source Type: Journal    
DOI: 10.1002/acr.21991     Document Type: Article

References (21)

1. Seror R, Ravaud P, Bowman S, Baron G, Tzioufas A, Theander E, et al. EULAR Sjögren's Syndrome Disease Activity Index (ESSDAI): development of a consensus systemic disease activity index in primary Sjögren's syndrome. Ann Rheum Dis 2010; 69: 1103-9.
2. Seror R, Mariette X, Bowman S, Baron G, Gottenberg JE, Boostma H, et al, for the European League Against Rheumatism Sjögren's Task Force. Accurate detection of changes in disease activity in primary Sjögren's syndrome by the European League Against Rheumatism Sjögren's Syndrome Disease Activity Index. Arthritis Care Res (Hoboken) 2010; 62: 551-8.
3. Vitali C, Palombi G, Baldini C, Benucci M, Bombardieri S, Covelli M, et al. Sjögren's Syndrome disease damage index and disease activity index: scoring systems for the assessment of disease damage and disease activity in Sjögren's syndrome, derived from an analysis of a cohort of Italian patients. Arthritis Rheum 2007; 56: 2223-31.
4. Bowman SJ, Sutcliffe N, Isenberg DA, Goldblatt F, Adler M, Price E, et al. Sjögren's Systemic Clinical Activity Index (SCAI): a systemic disease activity measure for use in clinical trials in primary Sjögren's syndrome. Rheumatology (Oxford) 2007; 46: 1845-51.
5. Bowman SJ, Booth DA, Platts RG,. Measurement of fatigue and discomfort in primary Sjögren's syndrome using a new questionnaire tool. Rheumatology (Oxford) 2004; 43: 758-64.
6. Bowman SJ, Booth DA, Platts RG, Field A, Rostron J,. Validation of the Sicca Symptoms Inventory for clinical studies of Sjögren's syndrome. J Rheumatol 2003; 30: 1259-66.
7. Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexander EL, Carsons SE, et al. Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 2002; 61: 554-8.
8. Bax HI, Vriesendorp TM, Kallenberg CG, Kalk WW,. Fatigue and immune activity in Sjögren's syndrome [abstract]. Ann Rheum Dis 2002; 61: 284.
9. Symmons DP, Coppock JS, Bacon PA, Bresnihan B, Isenberg DA, Maddison P, et al, for the members of the British Isles Lupus Assessment Group (BILAG): development and assessment of a computerized index of clinical disease activity in systemic lupus erythematosus. Q J Med 1988; 69: 927-37.
10. Hay EM, Bacon PA, Gordon C, Isenberg DA, Maddison P, Snaith ML, et al. The BILAG index: a reliable and valid instrument for measuring clinical disease activity in systemic lupus erythematosus. Q J Med 1993; 86: 447-58.
11. Liang MH, Socher SA, Larson MG, Schur PH,. Reliability and validity of six systems for the clinical assessment of disease activity in systemic lupus erythematosus. Arthritis Rheum 1989; 32: 1107-18.
12. Smolen JS, Breedveld FC, Burmester GR, Combe B, Emery P, Kalden JR, et al. Consensus statement on the initiation and continuation of tumour necrosis factor blocking therapies in rheumatoid arthritis. Ann Rheum Dis 2000; 59: 504-5.
13. Chang E, Abrahamowicz M, Ferland D, Fortin PR,. Comparison of the responsiveness of lupus disease activity measures to changes in systemic lupus erythematosus activity relevant to patients and physicians. J Clin Epidemiol 2002; 55: 488-97.
14. Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH, for the Committee on Prognosis Studies in SLE. Derivation of the SLEDAI: a disease activity index for lupus patients. Arthritis Rheum 1992; 35: 630-40.
15. Kwoh CK, O'Connor GT, Regan-Smith MG, Olmstead EM, Brown LA, Burnett JB, et al. Concordance between clinician and patient assessment of physical and mental health status. J Rheumatol 1992; 19: 1031-7.
16. Lu TY, Ng KP, Cambridge G, Leandro MJ, Edwards JC, Ehrenstein M, et al. A retrospective seven-year analysis of the use of B cell depletion therapy in systemic lupus erythematosus at University College London Hospital: the first fifty patients. Arthritis Rheum 2009; 61: 482-7.
17. Watson RM, Scheel JN, Petri M, Lee LA, Bias WB, McLean RH,. Neonatal lupus erythematosus syndrome: analysis of C4 allotypes and C4 genes in 18 families. Medicine (Baltimore) 1992; 71: 84-95.
18. Hay EM, Thomas E, Pal B, Hajeer A, Chambers H, Silman AJ,. Weak association between subjective symptoms or and objective testing for dry eyes and dry mouth: results from a population based study. Ann Rheum Dis 1998; 57: 20-4.
19. Vivino FB, Al-Hashimi I, Khan Z, LeVeque FG, Salisbury PL III, Tran-Johnson TK, et al. Pilocarpine tablets for the treatment of dry mouth and dry eye symptoms in patients with Sjögren's syndrome: a randomized, placebo-controlled, fixed-dose, multicenter trial. Arch Intern Med 1999; 159: 174-81.
20. Petrone D, Condemi JJ, Fife R, Gluck O, Cohen S, Dalgin P,. A double-blind, randomized, placebo-controlled study of cevimeline in Sjögren's syndrome patients with xerostomia and keratoconjunctivitis sicca. Arthritis Rheum 2002; 46: 748-54.
21. Daniels TE, Cox D, Shiboski CH, Schiodt M, Wu A, Lanfranchi H, et al, for the Sjögren's International Collaborative Clinical Alliance Research Groups. Associations between salivary gland histopathologic diagnoses and phenotypic features of Sjögren's syndrome among 1,726 registry participants. Arthritis Rheum 2011; 63: 2021-30.